KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Enterprise Value (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.87%
Dec 31, 2025 3.35%
Sep 30, 2025 -17.65%
Jun 30, 2025 8.88%
Mar 31, 2025 26.42%
Dec 31, 2024 -32.87%
Sep 30, 2024 3.12%
Jun 30, 2024 4.19%
Mar 31, 2024 11.29%
Dec 31, 2023 68.50%
Sep 30, 2023 -1.44%
Jun 30, 2023 -8.51%
Mar 31, 2023 -239.18%
Dec 31, 2022 18.93%
Sep 30, 2022 -59.79%
Jun 30, 2022 -9.76%
Mar 31, 2022 18.58%
Dec 31, 2021 37.80%
Sep 30, 2021 -59.87%
Jun 30, 2021 23.51%
Mar 31, 2021 0.76%
Dec 31, 2020 13.86%
Sep 30, 2020 -8.22%
Jun 30, 2020 -42.55%
Mar 31, 2020 10.09%
Dec 31, 2019 57.27%
Sep 30, 2019 4.16%
Jun 30, 2019 17.27%
Mar 31, 2019 10.25%
Dec 31, 2018 2.06%
Sep 30, 2018 -1.79%
Jun 30, 2018 8.63%
Mar 31, 2018 22.81%
Dec 31, 2017 -0.79%
Sep 30, 2017 -5.41%
Jun 30, 2017 -2.16%
Mar 31, 2017 -0.82%
Dec 31, 2016 -0.28%
Sep 30, 2016 -8.41%
Jun 30, 2016 -0.85%
Mar 31, 2016 -10.70%
Dec 31, 2015 -0.84%
Sep 30, 2015 -3.76%
Jun 30, 2015 -10.60%
Mar 31, 2015 -0.34%
Dec 31, 2014 3.74%
Sep 30, 2014 -7.21%
Jun 30, 2014 -32.25%
Mar 31, 2014 -2.07%
Dec 31, 2013 -73.81%
Sep 30, 2013 49.31%
Jun 30, 2013 -3.51%
Mar 31, 2013 11.60%
Dec 31, 2012 5.17%
Sep 30, 2012 -333.82%
Jun 30, 2012 -39.03%
Mar 31, 2012 79.62%
Dec 31, 2011 7.74%
Sep 30, 2011 -69.40%
Jun 30, 2011 -83.35%
Mar 31, 2011 59.74%
Dec 31, 2010 -53.95%
Sep 30, 2010 -52.75%
Jun 30, 2010 -40.20%
Mar 31, 2010 64.54%
Dec 31, 2009 -5.78%
Sep 30, 2009 -38.42%
Jun 30, 2009 -276.34%